Literature DB >> 12121035

Early infantile form of spinal muscular atrophy (Werdnig-Hoffmann disease) with prolonged survival.

Janina Borkowska1, Sabine Rudnik-Schoneborn, Irena Hausmanowa-Petrusewicz, Klaus Zerres.   

Abstract

According to several previously used classification systems, spinal muscular atrophy (SMA) type I has been characterised by an early onset (< 6 months), severe course (patients are never able to sit without support) and fatal prognosis (death before 2-4 years). We report 36 out of 349 SMA type I patients (10%) who had an onset before 6 months and never learnt to sit but survived at least beyond their fifth birthday, in spite of total immobility and frequent respiratory infections. These data support a classification avoiding age at death as a criterion. In the subgroup of type I with prolonged survival, there was no difference in life span between those individuals who had an onset of disease at birth or before and those with symptoms starting after 3 months. Life span may be related to the ability to withstand repeated respiratory insult, as several of the sibships with children affected by similar neuromuscular compromise showed discordant ages at death. "Chronic" SMA I and SMA II may represent overlapping phenotypes as our index patients with SMA I had a sib with SMA.

Entities:  

Mesh:

Year:  2002        PMID: 12121035

Source DB:  PubMed          Journal:  Folia Neuropathol        ISSN: 1509-572X            Impact factor:   2.038


  5 in total

1.  Demographic characteristics of SMA type 1 patients at a tertiary center in Turkey.

Authors:  Barış Ekici; Betül Bozkurt; Burak Tatlı; Mine Calışkan; Nur Aydınlı; Meral Ozmen
Journal:  Eur J Pediatr       Date:  2011-10-21       Impact factor: 3.183

2.  Survival analysis of spinal muscular atrophy type I.

Authors:  Hyun Bin Park; Soon Min Lee; Jin Sung Lee; Min Soo Park; Kook In Park; Ran Namgung; Chul Lee
Journal:  Korean J Pediatr       Date:  2010-11-30

3.  Compressive Neuropathy of the Facial Nerve Presenting as Bell's Palsy in a Pediatric Patient on High-Frequency Oscillatory Ventilation.

Authors:  Adebayo Adeyinka; Brisa Gulari-Jones; Keneisha Bailey-Correa; Louisdon Pierre
Journal:  Cureus       Date:  2020-05-13

Review 4.  Longitudinal natural history of type I spinal muscular atrophy: a critical review.

Authors:  Eugenio Mercuri; Simona Lucibello; Marco Perulli; Giorgia Coratti; Roberto de Sanctis; Maria Carmela Pera; Marika Pane; Jacqueline Montes; Darryl C de Vivo; Basil T Darras; Stephen J Kolb; Richard S Finkel
Journal:  Orphanet J Rare Dis       Date:  2020-04-05       Impact factor: 4.123

5.  Clinical Trial and Postmarketing Safety of Onasemnogene Abeparvovec Therapy.

Authors:  John W Day; Jerry R Mendell; Eugenio Mercuri; Richard S Finkel; Kevin A Strauss; Aaron Kleyn; Sitra Tauscher-Wisniewski; Francis Fonyuy Tukov; Sandra P Reyna; Deepa H Chand
Journal:  Drug Saf       Date:  2021-08-12       Impact factor: 5.606

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.